|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
00455 TIANDA PHARMA
Nominal 
0.105 +0.002 (+1.942%) | 2026/06 - Interim HKD(K$) | %Chg (Compare to Interim) | 2025/12 HKD(K$) | 2024/12 HKD(K$) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | |
| Turnover | 164,222 | 20.190% | 322,945 | 329,937 | 532,089 | 410,021 |
| Cost of Sales | (98,078) | 22.519% | (189,635) | (177,913) | (276,557) | (221,380) |
| Gross Profit | 66,144 | 16.895% | 133,310 | 152,024 | 255,532 | 188,641 |
| 2026/06 - Interim HKD(K$) | %Chg (Compare to Interim) | 2025/12 HKD(K$) | 2024/12 HKD(K$) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | (14,762) | -- | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | (31,237) | -7.926% | (69,328) | (54,340) | (25,694) | (47,890) | |
| Taxation | (985) | -- | (926) | (7,074) | 689 | 3,647 | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | (28) | -- | 257 | 43 | 850 | 3,266 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (32,250) | -2.970% | (69,997) | (61,371) | (24,155) | (40,977) | |
| 2026/06 - Interim HKD(K$) | %Chg (Compare to Interim) | 2025/12 HKD(K$) | 2024/12 HKD(K$) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | |
| Net Finance Costs / (Income) | 2,117 | 15.936% | 3,533 | 3,754 | 1,914 | 1,785 |
| Depreciation & Amortisation | 20,486 | 8.489% | -- | 38,232 | 36,407 | 37,687 |
| Directors' Emoluments | -- | -- | -- | 420 | 421 | 315 |
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/12 | 2024/12 | 2023/12 | 2022/12 | |
| Auditor's Opinion Status | N/A | -- | Unqualified | Unqualified | Disclaimer | Unqualified |
Market Valuation Indicators
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/12 | 2024/12 | 2023/12 | 2022/12 | |
| EPS (cts) | -1.500 | -3.226% | -3.260 | -2.850 | -1.120 | -1.910 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.260 | 0.260 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | 0.007 | (0.005) | (0.023) | 0.036 |
| NBV per share ($) | 0.205 | -- | 0.212 | 0.235 | 0.275 | 0.292 |
| Remarks: | Real time quote last updated: 11/08/2026 18:00 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K$) | HKD -32,250 |
| %Change | -2.970% |
| EPS / (LPS) | HKD -0.015 |
| NBV Per Share ($) | HKD 0.205 |